Consensus Ventas, Inc.

Stocks

VTR

US92276F1003

Specialized REITs

Market Closed - NYSE 16:03:20 2026-09-01 EDT			5-day change	1st Jan Change
92.07 ^USD	+0.99%		-1.50%	+18.98%

09-01	Wells Fargo Adjusts Price Target on Ventas to $104 From $96, Maintains Overweight Rating	MT
08-31	Barclays Adjusts Price Target on Ventas to $102 From $99, Keeps Equalweight Rating	MT

Evolution of the Average Target: Ventas, Inc.

Evolution of the Target Price: Ventas, Inc.

Changes in Analyst Recommendations: Ventas, Inc.

c1310743b4c29ee72b9a1b170ce38ff3.3xWcXaR5c68CPrrkKZ46H_8j1siSnw3FeEH6ie_uJkc.iSfOM8kIHcBLdIuKXe8LKY9LnI7T6UeCMSC4w6WKSRCQItkcwUwsnmZXjg~37fc72f163b345dd2058c240b8acb2f2

Analysts' recommendations: Ventas, Inc.

09-01	Wells Fargo Adjusts Price Target on Ventas to $104 From $96, Maintains Overweight Rating	MT
08-31	Barclays Adjusts Price Target on Ventas to $102 From $99, Keeps Equalweight Rating	MT
08-14	Ventas Earnings Growth Supported by Strong Senior Housing Trends, RBC Says	MT
08-14	RBC Adjusts Price Target on Ventas to $99 From $98, Maintains Outperform Rating	MT
08-12	Jefferies Adjusts Price Target on Ventas to $102 From $109, Maintains Buy Rating	MT
08-11	BMO Capital Adjusts Price Target on Ventas to $107 From $105, Keeps Outperform Rating	MT
08-05	Argus Research Adjusts Ventas Price Target to $98 From $92	MT
08-04	Citigroup Adjusts Price Target on Ventas to $110 From $100, Maintains Buy Rating	MT
08-03	Evercore ISI Adjusts Price Target on Ventas to $101 From $96, Maintains Outperform Rating	MT
08-03	BMO Capital Adjusts Price Target on Ventas to $105 From $100, Maintains Outperform Rating	MT
07-30	BNP Paribas Adjusts Ventas Price Target to $110 From $93, Maintains Outperform Rating	MT
07-24	Goldman Sachs Adjusts Price Target on Ventas to $114 From $110, Maintains Buy Rating	MT
07-22	Mizuho Adjusts Price Target on Ventas to $104 From $98, Maintains Outperform Rating	MT
07-15	Jefferies Adjusts Price Target on Ventas to $109 From $100, Maintains Buy Rating	MT
07-10	Scotiabank Adjusts Price Target on Ventas to $93 From $88	MT
07-01	Evercore ISI Adjusts Ventas Price Target to $96 From $95, Maintains Outperform Rating	MT
06-18	Scotiabank Adjusts Price Target on Ventas to $88 From $95, Maintains Sector Perform Rating	MT
06-16	Deutsche Bank Lifts Price Target on Ventas to $100 From $95, Keeps Buy Rating	MT
06-01	Wells Fargo Adjusts Price Target on Ventas to $96 From $93, Maintains Overweight Rating	MT
05-26	BofA Adjusts Price Target on Ventas to $110 From $102	MT
05-22	Baird Adjusts Price Target on Ventas to $98 From $97, Maintains Outperform Rating	MT
05-22	Mizuho Adjusts Price Target on Ventas to $98 From $94, Maintains Outperform Rating	MT
05-21	Scotiabank Adjusts Price Target on Ventas to $95 From $93, Maintains Sector Perform Rating	MT
05-19	Goldman Sachs Adjusts Price Target on Ventas to $110 From $100, Maintains Buy Rating	MT
05-13	Jefferies Adjusts Price Target on Ventas to $100 From $97, Maintains Buy Rating	MT

More recommendations

Healthcare REITs

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	VENTAS, INC.					+10.33%
	WELLTOWER INC.					+8.77%
	HEALTHPEAK PROPERTIES, INC.					+10.72%
	OMEGA HEALTHCARE INVESTORS, INC.					+13.61%
	AMERICAN HEALTHCARE REIT, INC.					+15.92%
	CARETRUST REIT, INC.					+16.52%
	AEDIFICA					+22.53%
	HEALTHCARE REALTY TRUST INCORPORATED					+13.36%
	SABRA HEALTH CARE REIT, INC.					+11.75%
	CHARTWELL RETIREMENT RESIDENCES					+25.98%
	Average					+14.95%
	Weighted average by Cap.					+10.67%